Abstract
Skeletal muscle begins to develop in the mesodermic somites at 2–3 weeks’ gestation. At 4–5 gestational weeks (GW), the myotomes develop as a syncytium of nuclei and cytoplasm. At 7–9 GW, the syncytium elongates, and cells fuse and form the primitive myotubes. These are multinucleated cells with nuclei situated centrally in a hollow tube of thin cytoplasm. This process continues, with the newest myotubes being the smallest. Actin and myosin filaments develop and form myofibrils in the myotubes. At 10 GW, the embryonic muscle is well formed into myotubes. The muscle fibers are larger, and striations are evident. At 12 GW, motor end plates and muscle spindles are developing. At 13 GW, the myofibrils become thicker in the older fibers, and new smaller myotubes continue to develop. At 15 GW, two populations of muscle fibers are present: (1) large, more mature fibers with peripheral nuclei and filled-in cytoplasm and (2) smaller, more immature myotubes. After 16 GW, all of the muscle fibers continue to increase in size, and the myotubes gradually disappear. However, the pattern of large and small muscle fibers persists into the postnatal period and into the second year of life. The
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
25 Muscle Disease
Adams RD (1975) Disease of muscle, a study of pathology, 3rd edn. Harper & Row, Hagerstown, MD, pp 2–53.
Karpati G (2003) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 1–3.
Dubowitz V (1985) Muscle biopsy a practical approach, 2nd edn. Bailliere Tindall, London.
Anderson LVB (2003) Dystrophinopathies. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 6–46.
Hoffman EP, Pegoraro E (2003) Lasminin α2 (merosin) gene mutations. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 37–41.
Padberg GW (2003) Large telomeric deletion disease: facioscapularhumeral dystrophy. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 119–122.
Thornton C (2003) The myotonic dystrophies. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 108–114.
Carpenter S (2003) Abnormalities in nuclear positioning (centronuclear myopathies). In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 57–59.
Mandel JL, Laporte J, Buj-Bello A, Sewry C, Wallgren-Pettersson C (2003) X-linked myotubular myopathy. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 124–129.
Goebel HH, Laing NG (2003) Nemaline myopathies. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 74–76.
MacLennan DH, Loke JCP (2003) Malignant hyperthermia and central core disease associated with defects in Ca2+ channels of the sarcotubular system. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 99–102.
Goebel HH (2003) Congenital fiber type disproportion. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 130–131.
Engel AG, Hohlfeld R, Banker BQ (1994) Inflammatory myopathies. In: Engel AG, Franzini-Armstrong C (eds) Myology, Vol 2. McGraw-Hill, New York, pp 1335–1418.
Eller RO, Cumming WJK, Mahon M, Ellison DW (2002) Diseases of muscle. In: Graham DI, Lantos PL (eds) Greenfield’s neuropathology, 7th edn, Vol 2. Arnold, London, pp 677–756.
Shoubridge EA, Molnar MJ (2003) Oxidative phosphorylation defects. In: Karpati G (ed) Structural and molecular basis of skeletal muscle disease. ISN Neuropath Press, Basel, pp 202–213.
Rutledge ML, Hawkins EP, Langston C (1986) Skeletal muscle growth failure in premature newborns by chronic pancuronium treatment. J Pediatr 109:883–886.
Szigeti K, Gulum MS, Armstrong A, Belmont JW, Miler G, Lupski J (2003) Disturbance of muscle fiber differentiation in congenital hypomyelinating neuropathy caused by a novel myelin protein zero mutation. Ann Neurol 54:389–402.
Rights and permissions
Copyright information
© 2007 Springer
About this chapter
Cite this chapter
(2007). Muscle Disease. In: Pediatric Neuropathology. Springer, Tokyo. https://doi.org/10.1007/978-4-431-49898-8_25
Download citation
DOI: https://doi.org/10.1007/978-4-431-49898-8_25
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-70246-7
Online ISBN: 978-4-431-49898-8
eBook Packages: MedicineMedicine (R0)